Figure 4
From: A potential primary endpoint for clinical trials in glaucoma neuroprotection
Location of progressing points as a function of baseline severity. The legend shows the relationship between baseline total deviation sensitivity (dB) and greyscale. The numbers inside each box (0 or 1) show whether that test location progressed based upon Endpoint A. Left: both eyes of the same patient who reached the endpoint. Note that there are 5 locations adjacent to a deep baseline scotoma. Right: both eyes of the same patient who reached the endpoint. Note that there are 5 locations inside a relatively shallow baseline scotoma.
